Medical Cannabis Portfolio
Chronic Pain, Multiple Sclerosis, Palliative Care
Approved/CommercialActive
Key Facts
Indication
Chronic Pain, Multiple Sclerosis, Palliative Care
Phase
Approved/Commercial
Status
Active
Company
About Tilray
Tilray is a diversified, multi-national cannabis and consumer packaged goods company formed through the merger of Tilray and Aphria in 2021. It holds a significant market share in the Canadian adult-use cannabis market and has expanded its portfolio through strategic acquisitions, including HEXO, Truss Beverage Co., and Breckenridge Distillery. The company's strategy focuses on leveraging its cultivation, manufacturing, and distribution capabilities across its core business units to drive growth in both the cannabis and non-cannabis CPG sectors.
View full company profile